Agios Pharma (AGIO) Tops Q3 EPS by 12c

Agios Pharma (NASDAQ: AGIO) reported Q3 EPS of ($1.78), $0.12 better than the analyst estimate of ($1.90). Revenue for the quarter came in at $12.9 million versus the consensus estimate of $10.54 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Tradeweb Markets (TW) PT Lowered to $151 at Raymond James
• Replimune (REPL) call put ratio 1 call to 1.3 puts with a focus on August options
• Agios Pharma (AGIO) PT Raised to $46 at BofA Securities